Verition Fund Management’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,681
| Closed | -$348K | – | 3075 |
|
|
2025
Q1 | $348K | Buy |
27,681
+12,243
| +79% | +$154K | ﹤0.01% | 2162 |
|
|
2024
Q4 | $163K | Buy |
15,438
+4,975
| +48% | +$52.5K | ﹤0.01% | 2358 |
|
|
2024
Q3 | $152K | Sell |
10,463
-16,462
| -61% | -$239K | ﹤0.01% | 2244 |
|
|
2024
Q2 | $229K | Buy |
+26,925
| New | +$229K | ﹤0.01% | 1874 |
|
|
2023
Q2 | – | Sell |
-23,869
| Closed | -$155K | – | 2229 |
|
|
2023
Q1 | $155K | Buy |
+23,869
| New | +$155K | ﹤0.01% | 1665 |
|